Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical Pharmacology

• Publication date

  2001-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(01)00608-6PMID 11377387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates

  2007cited by this paper
• Species Dependence for Binding of Small Molecule Agonist and Antagonists to the C5a Receptor on Polymorphonuclear Leukocytes

  2001cited by this paper
• Analysis of receptor/ligand interactions using whole-molecule randomly-mutated ligand libraries.

  2000cited by this paper
• Response‐selective C5a agonists: differential effects on neutropenia and hypotension in the rat

  1999cited by this paper
• Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit

  1999cited by this paper
• C5a Receptor Activation

  1999cited by this paper
• Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.

  1999cited by this paper
• Pharmacological characterization of antagonists of the C5a receptor

  1999cited by this paper
• Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.

  1998cited by this paper
• Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors.

  1998cited by this paper
• cDNA Cloning and Characterization of Rat C5a Anaphylatoxin Receptor

  1997cited by this paper
• Molecular cloning and expression of the functional rat C5a receptor.

  1997cited by this paper
• The pharmacophore of the human C5a anaphylatoxin

  1994cited by this paper
• Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.

  1994cited by this paper
• Development of C5a receptor antagonists. Differential loss of functional responses.

  1994cited by this paper
• The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.

  1994cited by this paper
• Generation of chimeric C5a/formyl peptide receptors: towards the identification of the human C5a receptor binding site

  1994cited by this paper
• Inflammation: Basic Principles and Clinical Correlates

  1992cited by this paper
• Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor.

  1992cited by this paper
• Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.

  1992cited by this paper
• The chemotactic receptor for human C5a anaphylatoxin

  1991cited by this paper
• Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.

  1991cited by this paper
• Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

  1989cited by this paper
• Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.

  1989cited by this paper
• Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.

  1985cited by this paper
• Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

  1970cited by this paper

• International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors

  2013cites this paper
• GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor

  2011cites this paper
• VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.

  2009cites this paper
• Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.

  2008cites this paper
• Molecular analysis of the bovine anaphylatoxin C5a receptor

  2008cites this paper
• Genetic Analysis of the First and Third Extracellular Loops of the C5a Receptor Reveals an Essential WXFG Motif in the First Loop*

  2006cites this paper
• Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site*

  2005cites this paper
• The role of Pre-H2 domains of alpha- and delta-epithelial Na+ channels in ion permeation, conductance, and amiloride sensitivity.

  2004cites this paper
• The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein*

  2003cites this paper
• Structure-Function Relationships of Human C5a and C5aR1

  2003cites this paper
• Characterisation of C5a receptor agonists from phage display libraries.

  2003cites this paper
• A convergent solution-phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug.

  2003cites this paper
• The Role of Pre-H2 Domains of α- and δ-Epithelial Na+ Channels in Ion Permeation, Conductance, and Amiloride Sensitivity*

  2003cites this paper
• The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74 *

  2002cites this paper